Pasithea Therapeutics (KTTA) Cash from Discontinued Operations (2022 - 2023)
Pasithea Therapeutics recorded quarterly Cash from Discontinued Operations of 16895.0 in Q4 2023, down 50.18% quarter-over-quarter from 11250.0 in Q3 2023, and up 97.8% year-over-year from 8541.24 in Q4 2022.
Pasithea Therapeutics' Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 16895.0 for Q4 2023.
- In Q4 2023, Cash from Discontinued Operations rose 97.8% year-over-year to 16895.0; the TTM figure through Dec 2023 stood at 611278.0 (up 65.98% YoY), while the FY2023 annual figure was 611278.0, up 65.98% from the prior year.
- Cash from Discontinued Operations came in at 16895.0 for Q4 2023 at Pasithea Therapeutics, down from 11250.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 10698.0 in Q2 2022 to a low of 769680.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -16,895.00 |
| Dec 31, 2023 | -16,895.00 |
| Sep 30, 2023 | -11,250.00 |
| Sep 30, 2023 | -11,250.00 |
| Jun 30, 2023 | -399,689.00 |
| Jun 30, 2023 | -399,689.00 |
| Mar 31, 2023 | -183,444.00 |
| Mar 31, 2023 | -183,444.00 |
| Dec 31, 2022 | -769,680.00 |
| Dec 31, 2022 | -769,680.00 |
| Sep 30, 2022 | -626,357.00 |
| Sep 30, 2022 | -626,357.00 |
| Jun 30, 2022 | 10,698.00 |
| Jun 30, 2022 | 10,698.00 |
| Mar 31, 2022 | -411,252.00 |
| Mar 31, 2022 | -411,252.00 |